Achieve Life Sciences Inc banner

Achieve Life Sciences Inc
NASDAQ:ACHV

Watchlist Manager
Achieve Life Sciences Inc Logo
Achieve Life Sciences Inc
NASDAQ:ACHV
Watchlist
Price: 3.49 USD 5.12% Market Closed
Market Cap: $185.8m

Wall Street
Price Targets

ACHV Price Targets Summary
Achieve Life Sciences Inc

Wall Street analysts forecast ACHV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACHV is 15.88 USD with a low forecast of 10.1 USD and a high forecast of 26.25 USD.

Lowest
Price Target
10.1 USD
189% Upside
Average
Price Target
15.88 USD
355% Upside
Highest
Price Target
26.25 USD
652% Upside
Achieve Life Sciences Inc Competitors:
Price Targets
CALM
Cal-Maine Foods Inc
17% Upside
NYXH
Nyxoah SA
267% Upside
PTGX
Protagonist Therapeutics Inc
16% Upside
PRQR
ProQR Therapeutics NV
376% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-99%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-99%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACHV's stock price target?
Price Target
15.88 USD

According to Wall Street analysts, the average 1-year price target for ACHV is 15.88 USD with a low forecast of 10.1 USD and a high forecast of 26.25 USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett